atopic dermatitis chilrdren
Conditions
Interventions
None listed
Sponsors
Metabologenomics, Inc.
Nihonkai General Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Children aged more than or equal to 1 and less than 4 years old who are diagnosed with atopic dermatitis. (2) Subjects with guardian who showed understanding of the study procedures and agreement with participating the study by written informed consent prior to the study.
Exclusion criteria
Exclusion criteria: (1) Users of topical steroids that are classified as "very strong (group II)" or stronger in "Guidelines for the Treatment of Atopic Dermatitis 2018" by the Japanese Dermatological Association. (2) Subjects who have consumed medicines which affect the intestinal environment within the last 1 month to the observation observation start. (3) Subjects who have current medical history/anamnesis of severe cardiac, hepatic, renal or digestive diseases. (4) Subjects who are currently participating, or who have participated in other study for medicine of food within the last 4 weeks of the present study, or who possibly participate in another clinical trial after agreement of this study. (5) Subjects who have been determined ineligible by principal investigator or sub-investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Intestinal microbiome and intestinal metabolome | — |
Secondary
| Measure | Time frame |
|---|---|
| Relationship between gut microbiome, metabolome and skin clinical scores. | — |
Countries
Japan
Contacts
Public ContactYumiko Ichimura
Nihonkai General Hospital Medical support department
Outcome results
None listed